Updates are available Correction dated 2020-07-06
Click to view Correction: https://doi.org/10.1038/s41467-020-17025-7
-
Authors
Patel, Siddharth
Ashwanikumar, N.
Robinson, Ema
Xia, Yan
Mihai, Cosmin
Griffith, Joseph P. III
Hou, Shangguo http://orcid.org/0000-0001-6394-6467
Esposito, Adam A.
Ketova, Tatiana
Welsher, Kevin http://orcid.org/0000-0002-3180-279X
Joyal, John L.
Almarsson, Örn
Sahay, Gaurav
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Biomedical Imaging and Bioengineering (1R15EB021581)
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (1R01HL146736-01)
Cystic Fibrosis Foundation (SAHAY18G0)
- License Information
-
More Information
Article History
Received: 11 January 2019
Accepted: 14 January 2020
First Online: 20 February 2020
Change Date: 6 July 2020
Change Type: Correction
Change Details: An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Competing interests
: Y.X., C.M., A.A.E., T.K., J.L.J., and O.A. are Moderna Therapeutics employees and stockholders; G.S. has received funding from Moderna Therapeutics and is a stockholder. G.S., S.P., A.K.N., and E.R. (all OSU employees) and Moderna Therapeutics have a licensing agreement based on a patent filed as co-inventors. K.W., S.H., and J.G.III declare no competing interests.
